Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Cartilage oligomeric matrix protein: a new promising biomarker of liver fibrosis in chronic hepatitis C

In English

Författare

Summary, in English

Cartilage oligomeric matrix protein (COMP) is a biomarker of fibrosis in lung and skin. In this exploratory study we investigated the biomarker potential of COMP in chronic hepatitis C (CHC). We included consecutive patients with CHC admitted to the Department of Infectious Diseases, Lund University Hospital. COMP was analysed in serum using ELISA. The correlations between COMP and liver fibrosis, determined by transient elastography (TE) (n = 47) and liver biopsy (n = 28) were assessed. We also studied COMP prospectively in relation to antiviral treatment (n = 10). COMP correlated with the degree of liver fibrosis as assessed by TE (r = 0.71, p < 0.001) and liver biopsy (r(s) = 0.65, p < 0.001). After successful treatment of CHC, COMP decreased from 18 to 13 U/l (p = 0.011). We suggest that COMP is associated with the stage of liver fibrosis in CHC. The biomarker potential of COMP in CHC warrants further investigation.

Publiceringsår

2015

Språk

Engelska

Sidor

915-918

Publikation/Tidskrift/Serie

Infectious Diseases

Volym

47

Issue

12

Dokumenttyp

Artikel i tidskrift

Förlag

Informa Healthcare

Ämne

  • Infectious Medicine

Nyckelord

  • COMP
  • chronic hepatitis C
  • biomarker
  • transient elastography
  • liver
  • fibrosis

Status

Published

ISBN/ISSN/Övrigt

  • ISSN: 2374-4243